A detailed history of Diamond Hill Capital Management Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Diamond Hill Capital Management Inc holds 489,921 shares of BSX stock, worth $44.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
489,921
Previous 494,565 0.94%
Holding current value
$44.2 Million
Previous $38.1 Million 7.8%
% of portfolio
0.17%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$72.96 - $84.0 $338,826 - $390,096
-4,644 Reduced 0.94%
489,921 $41.1 Million
Q2 2024

Aug 08, 2024

SELL
$67.33 - $77.71 $2.57 Million - $2.96 Million
-38,145 Reduced 7.16%
494,565 $38.1 Million
Q1 2024

May 13, 2024

SELL
$57.6 - $68.62 $8.26 Million - $9.84 Million
-143,384 Reduced 21.21%
532,710 $36.5 Million
Q4 2023

Feb 05, 2024

SELL
$48.64 - $57.81 $1.54 Million - $1.83 Million
-31,741 Reduced 4.48%
676,094 $39.1 Million
Q3 2023

Nov 02, 2023

SELL
$50.19 - $54.68 $1.05 Million - $1.15 Million
-21,015 Reduced 2.88%
707,835 $37.4 Million
Q2 2023

Aug 08, 2023

SELL
$49.72 - $54.64 $1.03 Million - $1.13 Million
-20,709 Reduced 2.76%
728,850 $39.4 Million
Q1 2023

May 11, 2023

SELL
$45.09 - $50.03 $631,440 - $700,620
-14,004 Reduced 1.83%
749,559 $37.5 Million
Q4 2022

Feb 07, 2023

SELL
$39.56 - $47.22 $256,665 - $306,363
-6,488 Reduced 0.84%
763,563 $35.3 Million
Q3 2022

Nov 08, 2022

SELL
$36.71 - $109.66 $182,668 - $545,668
-4,976 Reduced 0.64%
770,051 $29.8 Million
Q2 2022

Aug 09, 2022

BUY
$35.24 - $47.1 $115,481 - $154,346
3,277 Added 0.42%
775,027 $28.9 Million
Q1 2022

May 11, 2022

SELL
$40.9 - $45.1 $6.75 Million - $7.44 Million
-164,995 Reduced 17.61%
771,750 $34.2 Million
Q4 2021

Feb 08, 2022

SELL
$38.07 - $44.87 $1.18 Million - $1.4 Million
-31,098 Reduced 3.21%
936,745 $39.8 Million
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $5.31 Million - $5.91 Million
-128,849 Reduced 11.75%
967,843 $42 Million
Q2 2021

Aug 03, 2021

SELL
$38.58 - $44.24 $4.17 Million - $4.78 Million
-108,112 Reduced 8.97%
1,096,692 $46.9 Million
Q1 2021

May 04, 2021

SELL
$35.27 - $39.67 $895,540 - $1.01 Million
-25,391 Reduced 2.06%
1,204,804 $46.6 Million
Q4 2020

Feb 08, 2021

BUY
$33.15 - $41.97 $2.16 Million - $2.74 Million
65,294 Added 5.61%
1,230,195 $44.2 Million
Q3 2020

Nov 09, 2020

SELL
$34.44 - $42.23 $17.1 Million - $21 Million
-497,065 Reduced 29.91%
1,164,901 $44.5 Million
Q2 2020

Aug 10, 2020

SELL
$30.19 - $39.11 $11.4 Million - $14.8 Million
-377,801 Reduced 18.52%
1,661,966 $58.4 Million
Q1 2020

May 05, 2020

BUY
$25.83 - $45.71 $4.67 Million - $8.26 Million
180,648 Added 9.72%
2,039,767 $66.6 Million
Q4 2019

Feb 07, 2020

SELL
$37.87 - $45.37 $5.37 Million - $6.43 Million
-141,828 Reduced 7.09%
1,859,119 $84.1 Million
Q3 2019

Oct 30, 2019

SELL
$40.31 - $43.45 $208,281 - $224,506
-5,167 Reduced 0.26%
2,000,947 $81.4 Million
Q2 2019

Aug 01, 2019

BUY
$34.91 - $42.98 $2.42 Million - $2.98 Million
69,262 Added 3.58%
2,006,114 $86.2 Million
Q1 2019

Apr 30, 2019

SELL
$32.91 - $40.75 $11.6 Million - $14.4 Million
-352,753 Reduced 15.41%
1,936,852 $74.3 Million
Q4 2018

Feb 11, 2019

SELL
$31.73 - $39.04 $19.8 Million - $24.3 Million
-622,930 Reduced 21.39%
2,289,605 $80.9 Million
Q3 2018

Nov 13, 2018

SELL
$32.83 - $38.63 $1,510 - $1,776
-46 Reduced -0.0%
2,912,535 $112 Million
Q2 2018

Aug 07, 2018

SELL
$26.84 - $34.32 $2.33 Million - $2.98 Million
-86,813 Reduced 2.89%
2,912,581 $95.2 Million
Q1 2018

May 02, 2018

SELL
$25.2 - $28.54 $625,212 - $708,077
-24,810 Reduced 0.82%
2,999,394 $81.9 Million
Q4 2017

Feb 06, 2018

BUY
$24.79 - $29.8 $354,769 - $426,467
14,311 Added 0.48%
3,024,204 $75 Million
Q3 2017

Oct 18, 2017

BUY
$26.26 - $29.17 $79 Million - $87.8 Million
3,009,893
3,009,893 $87.8 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Diamond Hill Capital Management Inc Portfolio

Follow Diamond Hill Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diamond Hill Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Diamond Hill Capital Management Inc with notifications on news.